Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: -0.05 (-1.52%)
Spread: 0.10 (3.125%)
Open: 3.30
High: 3.30
Low: 3.25
Prev. Close: 3.30
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: IS Solutions, Netservices, Plant Health Care...

Mon, 14th Sep 2009 09:51

Higher revenues helped software services group IS Solutions post broadly unchanged profits in the six months to June 30.Pre-tax profits for the period totalled £184,000, compared with £189,000 the previous year, as revenues soared to £5.12m from £3.64m. During the year, the company completed the purchase of headquarters on Sunbury on Thames and invested in establishing a branch office in the Indian sub-continent.Business communications group Netservices expects to post an operating loss of about £200,000 for the year to August 31 due to time it will take to develop relationships with clients.Depressed agricultural markets resulted in widening losses at natural plant supplement supplier Plant Health Care (PHC). Revenue in the six months to June 30 fell to $5.5m from $7.8m over the same period the previous year and pre-tax losses grew to $3.9m from $3.3m. PHC said that it had received large orders from the seed giant Monsanto for its Harpin seed treatment.China Wonder reported a drop in half year profits despite a 21% rise in sales revenue and said it continues to actively seek expansion opportunities both in the People's Republic of China and the United Kingdom. Pre-tax profit fell to £220,053 in the six month ended 30 June from £253,546 last time. Sales revenue for the period was £2.11m when compared to the £1,743,863 of sales for the same period in 2008.Expansion into Brazil and Germany helped Publishing Technologies, which provides online systems and management software to academic publishers, narrow losses sharply in the six months to June 30. Pre-tax losses totalled £99,000 for the period, compared with £299,000 for the same period the previous year. Revenue climbed to £7.7m from £7.3m.Environmental Recycling cut net losses from £1.8m to £0.54m in the half-year to June, on sales up to £427,000 (£179,000). The increasing recycling agenda has led to a considerable number of enquiries and negotiations in respect of the application of the PIM Process in various sectors, it said. The one major difficulty that remains is the ongoing litigation with the group's former CEO in Kyrgyzstan, it added.Intelligent Environments has signed a three year rolling contract with Home Retail priced on IE's transactional revenue model. IE will deliver a comprehensive electronic card statement system for Argos and Homebase store card customers.Biotech ValiRx has created a new wholly owned trading subsidiary, ValiMedix, to distribute a range of new diagnostic screening products acquired from Pasante Healthcare. The new diagnostic screening products principally comprise the Self Check screening products which allow an individual to check for potential health problems at an early stage. International Brand Licensing slipped into losses in the half year to June, losing £170,000 against a profit of £248,000. IBL said the figures should be considered against the backdrop of a very depressed sporting goods industry and a big exceptional gain last time. Timestrip, which makes labels indicating how long containers for food have been unsealed, saw higher revenues and reduced losses in the six months to June 30.. Revenues in the six months to June 30 climbed to £386m from £268m as losses narrowed to £453m from £697m.The firm also reported positive feedback from NHS trials of its TimeStripPlus technology which is used to show if a temperature sensitive product such as a drug has been exposed to incorrect temperatures.Angel Mining lost £1.5m in the 12 months ended 28 February versus £4.2m in 2008 following the reversal of impairment provisions of £3.2m linked to exploration costs at Black Angel in Greenland.The company, formerly known as Angus & Ross, wants to get Nalunaq in the south of Greenland into production this year then try and get the Black Angel mine producing by the end of 2010.Titanium Resources tumbled on Monday as it said sales fell to $19.8m in the six months ended 30 June from $32.5m previously, although some of that was due to the sale of a Bauxite mine last year.The loss after tax narrowed to $4.95m from $20.2m a year earlier as the cost of sales fell by 52% to $20.7m. 'We believe the company is on track to achieve operating profitability for H2 2009,' said boss John Sisay.Superconductor energy technology firm Zenergy Power has reported a big drop in revenue for the first half of 2009 to €0.2m from €1m and an increase in losses to £5m from £2.6m before.But it says continuing growth in its order backlog, €2.3m at the end of June, will 'smooth' its revenue recognition over reporting periods. 'However, in the short-term we expect lumpiness to be a feature of our revenue generation and this is certainly the case with our 2009 reporting.'Mobile marketing and advertising group Velti grew pre-tax profit to €2.7m in the six months to 30 June, up from €1.6m in 2008 on revenue 36% higher to €21.7m.'During the remainder of 2009 we will continue to build up momentum and grow the Company in a sustainable way with a strong focus on cash flow,' said chief executive Alex Moukas.Online retailer of ethical fashion and lifestyle products Adili saw pre-tax losses widen in the year to 30 April 2009 from £1.59m to £1.90m on sales that rose from £0.35m to £0.55m. Sales for the first five months of the current financial year are up 29% on a year earlier.The first half of 2009 saw loss before tax widen at biopharmaceutical contract manufacturer Angel Biotechnology to £0.52m from £0.46m, but revenue improved to £0.6m from £0.48m. 'Due to the structure of contracts we currently have, revenue recognition is necessarily delayed resulting in lower figures for H1 [first half] 2009 than might have been expected with the value of business signed. This situation is expected to be rectified in H2 [second half] 2009 and into 2010 as the revenues from these projects are recognised,' the company said.Security and fire alarm firm Westminster Group has won a tolling 12-month contract to provide 24-hour bodyguard protection to a rich individual and his family in the Middle East. The contract is worth £0.54m.
More News
24 Aug 2023 11:06

ValiRx interim loss widens as costs increase; hails Inaphaea progress

(Alliance News) - ValiRx PLC on Thursday reported an increased half-year loss amid higher costs, as it continued to focus on building its science-focused portfolio.

Read more
24 Aug 2023 09:59

ValiRx shares jump as H1 losses shrink

(Sharecast News) - Shares in ValiRx jumped nearly on Thursday after the biotech posted results for its first half, in which losses per share shrunk by a third.

Read more
14 Aug 2023 09:53

ValiRx subsidiary Inaphaea signs deal with Agility Life Sciences

(Sharecast News) - Life science company ValiRx announced on Monday that its wholly-owned subsidiary Inaphaea BioLabs has entered a collaborative services agreement with Agility Life Sciences.

Read more
14 Aug 2023 08:52

ValiRx signs collaborative services agreement with Agility

(Alliance News) - ValiRx PLC on Monday said its wholly-owned subsidiary, Inaphaea BioLabs Ltd, has entered into a collaborative services agreement with Agility Life Sciences Ltd.

Read more
19 Jul 2023 09:39

IN BRIEF: ValiRx subsidiary secures contract with UK biotech firm

ValiRx PLC - Essex, England-based life science company focused on early-stage cancer therapeutics and women's health - Says subsidiary Inaphea BioLabs Ltd will partner with an unnamed UK-based biotechnology company on a phenotypic assay to investigate anti-cancer properties using patient-derived cells from Inaphea's biobank. Adds Inaphea has started internal studies on ValiRx assets s VAL301 and Cytolytix CLX001. "This defined work programme involves a multi-stage project and is expected to complete at the end of September 2023," ValiRx says.

Read more
28 Jun 2023 20:25

TRADING UPDATES: All Things Considered raises funds to buy Sandbag

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Wednesday and not separately reported by Alliance News:

Read more
21 Jun 2023 15:43

UK shareholder meetings calendar - next 7 days

Thursday 22 June 
Alphawave IP Group PLCAGM
Angling Direct PLCAGM
Anglo Asian Mining PLCAGM
boohoo Group PLCAGM
Braime Group PLCAGM
Card Factory PLCAGM
Ergomed PLCAGM
Falcon Oil & Gas LtdAGM
Futura Medical PLCAGM
Good Energy Group PLCAGM
Grand Vision Media Holdings PLCAGM
Longboat Energy PLCAGM
MaxRets Ventures PLCAGM
Pathfinder Minerals PLCAGM
RBG Holdings PLCAGM
Robinson PLCAGM
Sanderson Design Group PLCAGM
Team17 Group PLCAGM
Trellus Health PLCAGM
Whitbread PLCAGM
Friday 23 June 
Cadogan Petroleum PLCAGM
Mears Group PLCAGM
Non-Standard Finance PLCAGM
Ocean Harvest Technology Group PLCAGM
Oxford Biomedica PLCAGM
Pelatro PLCAGM
Petrofac LtdAGM
Princess Private Equity Holding LtdAGM
Rathbones Group PLCGM re agreement regarding all-share combination with Invested Wealth & Investment Ltd
Supply@Me Capital PLCGM re open offer warrant holders
Vietnam Enterprise Investments LtdAGM
VPC Specialty Lending Investments PLCAGM
Monday 26 June 
Aterian PLCAGM
Capricorn Energy PLCAGM
Corre Energy BVAGM
Facilities by ADF PLCAGM
Lexington Gold LtdSGM re proposed acquisition of White Rivers Exploration Ltd
LifeSafe Holdings PLCAGM
Premier African Minerals LtdAGM
Vast Resources PLCGM re issuing new share capital
Volvere PLCAGM
Tuesday 27 June 
Acuity RM Group PLCAGM
Comptoir Group PLCAGM
Creo Medical Group PLCAGM
First Tin PLCAGM
Forward Partners Group PLCAGM
Galantas Gold CorpAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
Hamak Gold LtdAGM
ICG Enterprise Trust PLCAGM
Impellam Group PLCAGM
India Capital Growth Fund LtdAGM
Inspiration Healthcare Group PLCAGM
Instem PLCAGM
JD Sports Fashion PLCAGM
Kingfisher PLCAGM
Mercantile Ports & Logistics LtdGM re equity fundraising
Mobile Tornado Group PLCAGM
Revolution Beauty Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serabi Gold PLCAGM
Sondrel Holdings PLCAGM
Surface Transforms PLCAGM
Surgical Innovations Group PLCAGM
Trinity Exploration & Production PLCAGM
Wednesday 28 June 
Atalaya Mining PLCAGM
Avacta Group PLCAGM
Boku IncAGM
Cambridge Cognition Holdings PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Cobra Resources PLCAGM
Cora Gold LtdAGM
Dial Square Investments PLCAGM
Itaconix PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Panthera Resources PLCGM re directors’ authority to allot shares
Phoenix Spree Deutschland LtdAGM
Pineapple Power Corp PLCAGM
Polarean Imaging PLCAGM
RA International Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Shield Therapeutics PLCAGM
St Mark Homes PLCAGM
Star Phoenix Group LtdAGM
ValiRx PLCAGM
Velocys PLCAGM
Vertu Motors PLCAGM
Warpaint London PLCAGM
Westminster Group PLCAGM
Zenova Group PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
19 Jun 2023 11:51

IN BRIEF: ValiRx subsidiary to supply cell-based assays to OncoBone

ValiRx PLC - Essex, England-based life science company focused on early-stage cancer therapeutics and women's health - Says subsidiary Inaphaea Biolabs Ltd enters agreement with OncoBone Ltd. Says OncoBone clients will be able to access Inaphaea services. Notes Inaphaea is now confirmed as a cell-based assay supplier to OncoBone. Adds Inaphaea's services are now listed on scientist.com, a database website used by biotechnology and pharmaceutical companies.

Read more
16 Jun 2023 11:14

ValiRx terminates collaboration with Hokkaido University

(Sharecast News) - Life science company ValiRx has officially concluded its evaluation agreement with Hokkaido University, it announced on Friday.

Read more
16 Jun 2023 10:29

AIM WINNERS & LOSERS: Marlowe up on report of potential division sale

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
16 Jun 2023 09:09

ValiRx shares drop after cancer drug research dropped

(Alliance News) - ValiRx PLC shares fell on Friday, after it ended its evaluation agreement with Hokkaido University to research a potential drug.

Read more
16 Jun 2023 08:47

LONDON MARKET OPEN: Stocks head higher as pound tops USD1.28 again

(Alliance News) - Stock prices in London opened higher on Friday, taking their cue from Asian and US equities, while investors weighed recent interest rate decisions.

Read more
14 Jun 2023 14:37

ValiRx acquires assets of in-liquidation Imagen Therapeutics

(Sharecast News) - Life science company ValiRx has successfully completed the acquisition of the scientific assets of Imagen Therapeutics, it announced on Wednesday.

Read more
14 Jun 2023 11:35

ValiRx buys Imagen's scientific assets for cancer screening services

(Alliance News) - ValiRx PLC on Wednesday said it acquired the scientific assets of Imagen Therapeutics Ltd from its appointed liquidators for GBP170,000.

Read more
7 Jun 2023 12:44

ValiRx expands cancer research agreement with University of Barcelona

(Alliance News) - ValiRx PLC on Wednesday said it has expanded a pre-existing agreement with the University of Barcelona to test additional molecules as possible drugs for cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.